Lewis Nasr

Lewis Nasr

Université Saint Joseph de Beyrouth - Beirut / Lebanon
Medical and Health Sciences / Hematology
AD Scientific Index ID: 5070663
Saint Joseph University
person_outline Lewis Nasr's MOST POPULAR ARTICLES
1-) Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AMLNJ Short, N Daver, CD Dinardo, T Kadia, LF Nasr, W Macaron, M Yilmaz, ...Journal of Clinical Oncology 42 (13), 1499-1508, 2024312024
2-) Adhesion molecules in multiple myeloma oncogenesis and targeted therapyM Bou Zerdan, L Nasr, J Kassab, L Saba, M Ghossein, M Yaghi, ...International Journal of Hematologic Oncology 11 (2), IJH39, 2022242022
3-) A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agentsNJ Short, M Muftuoglu, F Ong, L Nasr, W Macaron, G Montalban-Bravo, ...Journal of Hematology & Oncology 16 (1), 73, 2023
4-) Systemic AL amyloidosis: current approach and future directionMB Zerdan, L Nasr, F Khalid, S Allam, Y Bouferraa, S Batool, M Tayyeb, ...Oncotarget 14, 384, 2023
5-) Central nervous system prophylaxis and treatment in acute leukemiasSY Wu, NJ Short, L Nasr, BS Dabaja, PQ FangCurrent treatment options in oncology 23 (12), 1829-1844, 2022152022